1. Skip to content

Mesothelioma Cancer Resources Blog

  • Clinical Trial Results Could Lead to New Mesothelioma “Standard of Care”

    In May, MesotheliomaHelp reported researchers announced that in preliminary results of a clinical trial for mesothelioma patients the patients had “a significantly longer survival.” Now, data from that trial of patients receiving the combination treatment of  bevacizumab with pemetrexed/cisplatin supports turning this triplet combination treatment into the new “standard of care.” In the findings presented …

    Label: Featured Story

    Posted on Monday, Sep 21, 2015
  • September 26, National Mesothelioma Awareness Day

    Once again, the mesothelioma community will come together for a day to raise awareness and to educate the public about the dangers of asbestos. On Saturday, Sept. 26, advocates, families, patients and the medical community from across the nation will reach out to the public for help in moving one step closer to their dream …

    Label: For Your Family

    Posted on Thursday, Sep 17, 2015
  • Orphan Drug New Immunotherapy Treatment

    Another pharmaceutical company is dedicating resources to help find an effective treatment for mesothelioma. Its efforts have led to an Orphan Drug Designation from the U.S. Food and Drug Administration, and comes on the heels of CRS-207 and tremelimumab, two other drugs developed to make a difference for mesothelioma patients, receiving the same designation from …

    Label: Treatment News

    Posted on Thursday, Sep 17, 2015
Load More News Load Older News